Anti-inflammatory properties of pro-inflammatory interferon-gamma.
about
Interleukin-12 is not essential for silicosis in mice.The unfolded protein response in multiple sclerosisIntravenous immunoglobulin and Alzheimer's disease: what now?Gene promoter methylation is associated with lung function in the elderly: the Normative Aging StudyAdjuvant interferon gamma in patients with pulmonary atypical Mycobacteriosis: a randomized, double-blind, placebo-controlled study.IFN-gamma impairs release of IL-8 by IL-1beta-stimulated A549 lung carcinoma cells.Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells.Early production of IL-22 but not IL-17 by peripheral blood mononuclear cells exposed to live Borrelia burgdorferi: the role of monocytes and interleukin-1.The Yin and Yang of bile acid action on tight junctions in a model colonic epithelium.Mice with a selective impairment of IFN-gamma signaling in macrophage lineage cells demonstrate the critical role of IFN-gamma-activated macrophages for the control of protozoan parasitic infections in vivoAccelerated atherosclerosis in systemic lupus erythematosus: role of proinflammatory cytokines and therapeutic approaches.TLR5 activation induces secretory interleukin-1 receptor antagonist (sIL-1Ra) and reduces inflammasome-associated tissue damage.Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitisIFN-γ inhibits gastric carcinogenesis by inducing epithelial cell autophagy and T-cell apoptosisAtherosclerosis in systemic lupus erythematosus.Active immunization against alpha-synuclein ameliorates the degenerative pathology and prevents demyelination in a model of multiple system atrophyThe integrated stress response prevents demyelination by protecting oligodendrocytes against immune-mediated damage.IFN-gamma signaling in the central nervous system controls the course of experimental autoimmune encephalomyelitis independently of the localization and composition of inflammatory foci.A post-transcriptional pathway represses monocyte VEGF-A expression and angiogenic activity.Key questions and answers about pregnancy-associated plasma protein-A.Impact of the New Generation Reconstituted Surfactant CHF5633 on Human CD4+ Lymphocytes.Inflammatory arthritis can be reined in by CpG-induced DC-NK cell cross talk.IL-22 is required for Th17 cell-mediated pathology in a mouse model of psoriasis-like skin inflammation.The GAIT system: a gatekeeper of inflammatory gene expression.Enhanced integrated stress response promotes myelinating oligodendrocyte survival in response to interferon-gammaIFN-γ and TNF-α synergistically induce mesenchymal stem cell impairment and tumorigenesis via NFκB signaling.Rapid dissemination of RET-transgene-driven melanoma in the presence of non-obese diabetic alleles: Critical roles of Dectin-1 and Nitric-oxide synthase type 2.Tumor necrosis factor-α and interferon-γ stimulate MUC16 (CA125) expression in breast, endometrial and ovarian cancers through NFκB.AMP-activated protein kinase restricts IFN-γ signaling.Autoantigen immunization at different sites reveals a role for anti-inflammatory effects of IFN-gamma in regulating susceptibility to experimental autoimmune encephalomyelitis.IFN{gamma} regulates retinal pigment epithelial fluid transport.Post-transcriptional regulatory networks in immunity.Should development of Alzheimer's disease-specific intravenous immunoglobulin be considered?Analysis of SOCS-3 promoter responses to interferon gamma.Molecular mechanisms of IL-18BP regulation in DLD-1 cells: pivotal direct action of the STAT1/GAS axis on the promoter level.Type I Interferon Supports Inducible Nitric Oxide Synthase in Murine Hepatoma Cells and Hepatocytes and during Experimental Acetaminophen-Induced Liver Damage.Diethylcarbamazine: possible therapeutic alternative in the treatment of alcoholic liver disease in C57BL/6 mice.IL-36γ/IL-1F9, an innate T-bet target in myeloid cells.Perinatal Brain Injury As a Consequence of Preterm Birth and Intrauterine Inflammation: Designing Targeted Stem Cell Therapies.Activation of interferon regulatory factor-3 via toll-like receptor 3 and immunomodulatory functions detected in A549 lung epithelial cells exposed to misplaced U1-snRNA
P2860
Q25257003-245650EC-71EC-47F7-AD46-7C89441FC786Q26797409-018DCB77-3390-49A5-A951-45EF87A4BE23Q27000371-49FA6880-5872-4006-BA42-977492790031Q28383778-16300DFE-A6DA-4C49-8864-7021905E298FQ33319304-B18C54D6-0356-46F4-8E9A-FABB66D98947Q33370417-09E5E07C-8098-4810-A040-6567C7677793Q33619976-A2A86C0D-9BC2-4CB1-92CD-5343A37DCA1CQ33728489-420689A7-F444-4CAD-9ADE-374E04717368Q33740929-C50BBFC1-9563-4F27-8A83-99BED670E0A9Q33915925-7B38B051-35B9-4C83-8D76-04C690577959Q34170097-5F6A9BA6-8622-448C-BD79-4C65C8C693CCQ34451414-8F77ED0F-2EB0-458E-AF8F-10FAF08DFD1CQ34575334-F5190567-521B-4265-B2E5-7084F0521E14Q35116625-C2486167-9404-4BE2-B4E5-737B2DE17ACCQ35525108-8C56499F-4A3F-4E06-A5C1-EDE15E3C2677Q35544737-324FDEE5-5F7A-40FC-9A69-A4F4CABC06EAQ35613472-B437D49A-C330-45D9-BFF7-314117D967C5Q35800253-A0566358-52EB-4DFE-9F0C-247E1F70F786Q35914617-54C877BE-1C07-4457-A075-42842FC208FDQ35947007-43E1FA45-5A33-4341-81CA-5E8E90B17889Q35989580-29EE3053-82F2-4BEA-BB2A-80ABD9C6B3F4Q36229564-B3A9F589-821F-4594-B931-A59CEC1D153AQ36383605-32912DDF-7CDA-4386-A40C-80C296229421Q36798907-B4DA990C-F4DB-43B9-97B2-EA8927DABCDFQ36943108-F6BE92B2-F483-4746-A4FD-66B51736EBDAQ36997344-1306D30F-EAB6-4D3C-A34D-C8C12D225951Q37012718-D05A7DDA-0FA3-41E5-BC33-486E27195AEDQ37046734-7A6E9DB1-6DA6-4F55-8157-B7C6B9E1970CQ37075106-759FD7E3-B72C-4D38-BB9F-956DE49FF018Q37398714-BA049C32-E011-47A3-B8DA-1CA2B89668B2Q37474481-E480C159-AC16-4524-AC5D-A17B0BCCB846Q38095507-865793C3-BF14-4EB0-9578-65F72AE84745Q38283308-C271FCBF-AD71-425A-985C-CD396818C926Q38345570-4383DDF4-1575-461F-9E8D-8A166245614CQ38358529-D27C418C-2000-4E1E-88C4-D7522C2A0740Q38616699-ED08DDD2-6480-43BB-94D7-BD558011F272Q39039913-AF3F6BD8-2501-4474-B65D-FBF0EDF3A150Q39253966-0914E638-93C7-4C25-9E20-565BC8D6C262Q39262680-82CE1A2D-655A-4BC4-A489-9AAD45ECF5AFQ39835471-DD81F448-AC7E-46E0-B537-FEA1D15B283E
P2860
Anti-inflammatory properties of pro-inflammatory interferon-gamma.
description
2003 nî lūn-bûn
@nan
2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Anti-inflammatory properties of pro-inflammatory interferon-gamma.
@ast
Anti-inflammatory properties of pro-inflammatory interferon-gamma.
@en
type
label
Anti-inflammatory properties of pro-inflammatory interferon-gamma.
@ast
Anti-inflammatory properties of pro-inflammatory interferon-gamma.
@en
prefLabel
Anti-inflammatory properties of pro-inflammatory interferon-gamma.
@ast
Anti-inflammatory properties of pro-inflammatory interferon-gamma.
@en
P1476
Anti-inflammatory properties of pro-inflammatory interferon-gamma.
@en
P2093
Heiko Mühl
Josef Pfeilschifter
P304
P356
10.1016/S1567-5769(03)00131-0
P577
2003-09-01T00:00:00Z